Ixilka Biotech ©

The way of success...
www.linkedin.com/posts/iximen...

a group of children are holding a cardboard sign that says thanks . ALT: a group of children are holding a cardboard sign that says thanks .

To test its functionality in the laboratory, we only need a saliva donor with this disease. If you know someone who has been diagnosed with this disease, please do not hesitate to contact us via the project email:
B-AxD2@ixilka.net

This biomolecule is a BINDER (a hyper-specific protein-binding peptide) designed by CRAID (ixilka.net/craid/), that binds to the defective GFAP' molecule (and only to this molecule) so that it does not cause structural damage to neurons.

Earlier this year, we started a new project (B-AxD) related to Alexander disease (AxD). This disease is a very rare neurodegenerative disorder that affects children from birth. We already have a candidate biomolecule for its treatment (continue...)

AI for advanced therapies
www.linkedin.com/pulse/ai-adv...

Research Technologies for New Medicines Ixilka Biotech S.L.

Research Technologies for New Medicines

www.linkedin.com/pulse/resear...

Explicame que es CRAID Shared via Copilot

What is CRAID? (Spanish) Copilot respond ...
copilot.microsoft.com/shares/bmqTo...

Breaking News: Scientists from the University of the Basque Country have discovered a groundbreaking molecule, WIN55.212-2, that reverses early cognitive damage caused by Alzheimer’s disease.

CORP - Collaboratory Open Research Project

New era of medicines comes from you ...

ixilka.net/CORP/

This is CRAID, the method and technology that makes real Precision Medicine

ixilka.net/CRAID/